1) Welcome to a new #accredited #tweetorial on the MoA & Renal Impact of Therapies Commonly Used in Pts with or At Risk for #DKD Progression: Improved Glycemic Control & #RAASi. Our expert author is Hans-Joachim Anders, MD, @hjanders_hans from @LMU_Uniklinikum...
1) Welcome to our new #accredited #tweetorial on the Pathophysiology of #DKD in #T2D: Traditional Teaching and New Insights. Our expert author is Hans-Joachim Anders, MD, @hjanders_hans from @LMU_Uniklinikum of @LMU_Muenchen 2) This #accredited #tweetorial series on...
1) Welcome to our new #tweetorial on optimizing #interprofessional & #multidisciplinary care & medical therapy for patients with #DKD. I am Sophia Ambruso DO, @sophia_kidney, from @CU_Kidney. 2) This #accredited #tweetorial series on #kidneydisease #DKD...
1) Welcome to a new #accredited #tweetorial on optimal deployment of the multidisciplinary, interprofessional team to ensure appropriate care of patients with type 2 diabetes #T2D & cardiac disease, #CaReMe #FOAMed. This program is accredited for 0.5h 🆓CE/#CME...
1) Welcome to a new #accredited #tweetorial from our good friends and #diabetes experts @GoggleDocs, specifically @drkevinfernando, @drpatrickholmes, & @AmarPut. They have put their 🗣️s together to provide us with a summary of the first-ever consensus statement...
1) Welcome to our new #accredited #tweetorial on risk stratification to identify the patient with #T2D and #DKD most at risk for rapid progression to advanced CKD. I am Christos Argyropoulos MD, PhD (@ChristosArgyrop), Division Chief, Nephrology, @UNMHSC. 2) This...